FDA Inspection 1197431 — Marek Smilowski, MD
The FDA completed an inspection of Marek Smilowski, MD on January 12, 2023 in Katowice. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 12, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Katowice (Poland)
Additional Details
Clinical Investigator (CI)